NHS · Neuberger High Yield Strategies Fund Inc.
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Asset Management — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHS
this stock
Neuberger High Yield Strategies Fund Inc.
|
$254.48M | -19.9% | — | — | 0.0% |
|
BLK
BlackRock, Inc.
|
$370.39B | +6.5% | +16.2% | 27.3 | 0.7% |
|
BX
Blackstone Inc.
|
$106.10B | -8.3% | +9.2% | 31.7 | 3.5% |
|
KKR
KKR & Co. Inc.
|
$97.09B | -16.0% | -11.0% | — | 1.6% |
|
BN
BROOKFIELD Corp /ON/
|
$92.35B | -9.8% | — | — | 0.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHS | -2.3% | -0.7% | -22.8% | -0.7% | -19.9% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -0.3% | -4.0% | -34.0% | -2.8% | -31.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.